Lv61
2790 积分 2022-05-24 加入
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
57分钟前
求助中
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
1小时前
已完结
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
1小时前
已完结
Research Advances in Mast Cell Biology and Their Translation Into Novel Therapies for Anaphylaxis
8小时前
已完结
Expert consensus on the application and management of therapeutic drugs for atopic dermatitis （2024）
2天前
已完结
Model-based Computational Precision Medicine to develop combination therapies for autoimmune diseases
3天前
已完结
A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040
4天前
已完结
Temporal trends in the prevalence of autoimmune diseases from 1990 to 2019
4天前
已完结
Nephrinuria and podocytopathies
6天前
已完结
Podocyte-targeted therapies — progress and future directions
6天前
已完结
皖公网安备34019202002308
